| Catalog | name | Description | price |
|---|---|---|---|
| R-C-589 | AZD8931 cas:848942-61-0 | Sapitinib(AZD8931)is a reversible,ATP competitive inhibitor of EGFR,ErbB2 and ErbB3 with IC50 of 4 nM,3 nM and 4 nM in cell-free assays,more potent than Gefitinib or Lapatinib against NSCLC cell,100-fold more selective for the ErbB family than MNK1 and Flt. | price> |
| R-C-597 | XL647 cas:781613-23-8 | XL647 is an orally bioavailable small-molecule RTK inhibitor that binds to and inhibits several tyrosine receptor kinases that play major roles in tumor cell proliferation and tumor vascularization,including EGFR,HER2,ERBB2,VEGFR and EphB4. | price> |
| R-C-608 | SU11274 cas:658084-23-2 | SU11274(PKI-SU11274)is a selective Met(c-Met)inhibitor with IC50 of 10 nM in cell-free assays,no effects on PGDFRβ,EGFR or Tie2.SU11274 induces autophagy,apoptosis and cell cycle arrest. | price> |
| R-C-611 | LDK378 cas:1032900-25-6 | LDK378 is a highly selective,orally bioavailable and ATP-competitive small molecule inhibitor of ALK(Anaplastic Lymphoma Kinase),a receptor tyrosine kinase considered to be an important lung cancer drug target. | price> |
| R-C-634 | CP868596 cas:670220-88-9 | Crenolanib(CP-868596,ARO 002)is a potent and selective inhibitor of PDGFRα/βwith Kd of 2.1 nM/3.2 nM in CHO cells,also potently inhibits FLT3,sensitive to D842V mutation not V561D mutation,>100-fold more selective for PDGFR than c-Kit,VEGFR-2,TIE-2,FGFR-2,EGFR,erbB2,and Src.Crenolanib helps to induce mitophagy. | price> |
| R-C-642 | PD153035HCl CAS No. 183322-45-4 | PD153035 HCl(SU-5271 HCl,AG1517 HCl,ZM 252868 HCl) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR,FGFR,CSF-1,InsR and Src. | price> |
| R-C-650 | KI8751 cas:228559-41-9 | Ki8751 is a cell-permeable quinolyloxyphenyl-urea compound that acts as a Flk-1 (VEGFR-2)-selective inhibitior in both cell-based and cell-free assays. | price> |
| R-C-651 | Rociletinib (CO-1686) cas:1374640-70-6 | Rociletinib(CO-1686,AVL-301)is an irreversible,mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays,respectively. | price> |
| R-C-655 | SKLB610 cas:1125780-41-7 | SKLB610 is a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. | price> |
| R-C-658 | Amuvatinib (MP-470) CAS :850879-09-3 | Amuvatinib(MP470)is an orally bioavailable multi-targeted tyrosine kinase inhibitor with potent activity against mutant c-Kit,PDGFRα,Flt3,c-Met and c-Ret.Amuvatinib(MP470)is also a DNA repair suppressor through suppression of DNA repair protein RAD51,thereby disrupting DNA damage repair. Antineoplastic activity. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


